PBC BioVet: Eine neue Dimension in der tierärztlichen Versorgung
May 12, 2024 20:05 ET
|
PBC Biomed Ltd
SHANNON, Irland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed ist stolz darauf, sein neuestes Unternehmen, PBC BioVet, vorzustellen: eine engagierte Tochtergesellschaft, die darauf abzielt, die...
Présentation de PBC BioVet : une nouvelle frontière dans les soins de santé vétérinaires
May 12, 2024 20:05 ET
|
PBC Biomed Ltd
SHANNON, Irlande, 13 mai 2024 (GLOBE NEWSWIRE) -- PBC Biomed est fier de dévoiler son tout nouveau projet, PBC BioVet, une filiale entièrement dédiée aux soins vétérinaires. Fermement résolu à...
Introducing PBC BioVet: A New Frontier in Veterinary Healthcare
May 12, 2024 20:05 ET
|
PBC Biomed Ltd
SHANNON, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed is proud to unveil its latest venture, PBC BioVet, a dedicated affiliate aimed at revolutionizing veterinary healthcare. With a...
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
January 31, 2024 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™...
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
January 25, 2024 12:03 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its...
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
November 21, 2023 07:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Strengthens Board with Biotech Executive
November 16, 2023 13:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) is pleased to announce that John Coleman has been...
Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
November 02, 2023 11:48 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today...
Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum
October 25, 2023 07:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it will be unveiling the new brand for its...
Global Advanced Wound Care Market was valued at US$ ~8.5 billion in 2022 and is Expected to grow at a Decent Rate of ~4% by 2027
January 23, 2023 09:00 ET
|
Medi-Tech Insights
BRUSSELS, BELGIUM, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Advanced wound care provides specialized treatment for chronic or non-healing wounds, which are defined as sores or wounds that have not...